发明名称 |
Polymer factor IX moiety conjugates |
摘要 |
Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is polyethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates. |
申请公布号 |
US9347054(B2) |
申请公布日期 |
2016.05.24 |
申请号 |
US201314076116 |
申请日期 |
2013.11.08 |
申请人 |
Nektar Therapeutics |
发明人 |
Bossard Mary J.;Stephenson Phillips Gayle |
分类号 |
C07K14/745;C12N9/96;A61K47/48;C12N9/64 |
主分类号 |
C07K14/745 |
代理机构 |
McDermott Will & Emery LLP |
代理人 |
Evans Susan T.;Wilson Mark A.;McDermott Will & Emery LLP |
主权项 |
1. A composition comprising a plurality of polyethylene glycol (PEG)-Factor IX moiety conjugates, the conjugates comprising a branched polyethylene glycol covalently attached via a spacer moiety comprised of one or more atoms to a Factor IX moiety that is either Factor IX or Factor IXa, where at least about 85% of the polyethylene glycol-Factor IX moiety conjugates in the composition are monoPEGylated. |
地址 |
San Francisco CA US |